MARKET

LNTH

LNTH

Lantheus Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.50
+0.12
+0.83%
Opening 14:41 07/09 EDT
OPEN
14.34
PREV CLOSE
14.38
HIGH
14.51
LOW
13.85
VOLUME
464.30K
TURNOVER
--
52 WEEK HIGH
29.04
52 WEEK LOW
8.67
MARKET CAP
968.40M
P/E (TTM)
23.24
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LNTH stock price target is 21.25 with a high estimate of 29.00 and a low estimate of 16.00.

EPS

LNTH News

More
Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting
Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic
Business Wire · 07/01 12:00
Lantheus Holdings Inc (LNTH): Hedge Funds Are Adding
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain
Insider Monkey · 06/22 16:11
Lantheus Completes Merger with Progenics
Business Wire · 06/22 12:00
Merger Arbitrage Mondays - 2 Chinese Companies Choose To Go Private
Seeking Alpha - Article · 06/22 10:38
Independent Bank Group Set to Join S&P SmallCap 600
PR Newswire · 06/17 22:33
S&P Dow Jones Indices Reports 'Independent Bank Group Set to Join S&P SmallCap 600'
https://us.spindices.com/documents/indexnews/announcements/20200617-1167762/1167762_6independent6progenics.pdf?force_download=true
Benzinga · 06/17 21:35
Lantheus Stockholders Approve Share Issuance For Merger with Progenics
Business Wire · 06/16 21:05
Lantheus shareholders back stock issuance in Progenics tie-up
Seeking Alpha - Article · 06/16 20:26

Industry

Medical Equipment, Supplies & Distribution
+0.25%
Healthcare Equipment & Supplies
-0.14%

Hot Stocks

Symbol
Price
%Change

About LNTH

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.
More

Webull offers kinds of Lantheus Holdings Inc stock information, including NASDAQ:LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.